STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION European Patent18720845.9Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION ColombiaNC2019/012386Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION China201880031431.0Filed on 2019-11-12
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Chile02843-2019Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Canada3058973Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION BrazilBR1120190209859Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION Read more about STAT3 INHIBITOR FORMULATION Australia2018248303Filed on 2018-04-05
RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION Read more about RECOMBINANT GP120 PROTEIN WITH V1-LOOP DELETION Patent Cooperation TreatyPCT/US2019/057268Filed on 2019-10-21
VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS Read more about VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US Patent 10,588,984Filed on 2018-09-26
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY US Patent 11,389,480Filed on 2019-11-18